Usage: Balcoltra is indicated for use in females of reproductive potential for the prevention of pregnancy.
climara pro
(Estradiol and Levonorgestrel)
Bayer HealthCare Pharmaceuticals Inc.
Usage: Climara Pro is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause and the prevention of postmenopausal osteoporosis, specifically in women at significant risk. Non-estrogen medications should be considered first for osteoporosis prevention.
kyleena
(Levonorgestrel)
Bayer HealthCare Pharmaceuticals Inc.
Usage: Kyleena is indicated for the prevention of pregnancy for up to 5 years. If continued use is desired, the device should be replaced after 5 years.
liletta
(Levonorgestrel)
Allergan, Inc.
Usage: LILETTA is indicated for contraception to prevent pregnancy for up to 8 years and for the treatment of heavy menstrual bleeding for up to 5 years in patients using intrauterine contraception, with replacement required after 5 years if continued treatment is necessary.
mirena
(Levonorgestrel)
Bayer HealthCare Pharmaceuticals Inc.
Usage: Mirena is indicated for contraception, preventing pregnancy for up to 8 years, and for treating heavy menstrual bleeding for up to 5 years in women using it as their contraceptive method. Replacement is suggested at the end of the respective durations if treatment continues.
skyla
(Levonorgestrel)
Bayer HealthCare Pharmaceuticals Inc.
Usage: Skyla® is indicated for the prevention of pregnancy for up to 3 years. If continued use is desired, the system should be replaced after this duration.
twirla
(levonorgestrel/ethinyl estradiol)
Agile Therapeutics, Inc.
Usage: TWIRLA is indicated for contraception in women of reproductive potential with a BMI < 30 kg/m². However, caution is advised for those with a BMI ≥ 25 to < 30 kg/m² due to reduced effectiveness, and it is contraindicated for women with a BMI ≥ 30 kg/m².
tyblume
(Levonorgestrel and Ethinyl Estradiol)
Exeltis USA, Inc.
Usage: TYBLUME is indicated for females of reproductive potential to prevent pregnancy.